Trial · NCT07011732
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 21
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline on the Cohen-Mansfield Agitation Inventory-International Psychogeriatric Association (CMAI-IPA) Total Score at Week 14 | At Week 14 | |
| Secondary | Change from baseline on the Clinical Global Impressions-Severity (CGI-S) at Week 14 | At Week 14 | |
| Secondary | Change from baseline on the CMAI-IPA Domains at Week 14 | At Week 14 | |
| Secondary | Change from baseline on the CMAI Total Score at Week 14 | At Week 14 | |
| Secondary | Number of participants with Occurrence of Response at Week 14 | At Week 14 | As determined by CMAI-IPA Total Score changes of at least 30%, 40%, and 50% from baseline |
| Secondary | Change from baseline on the Neuropsychiatric Inventory/Neuropsychiatric Inventory -Nursing Home (NPI/NPI-NH) Total Score at Week 14 | At Week 14 | |
| Secondary | Number of participants with Adverse Events (AEs) | Up to Week 18 | |
| Secondary | Number of participants with Treatment Emergent AEs (TEAEs) | Up to Week 18 | |
| Secondary | Number of participants with Serious AEs (SAEs) | Up to Week 18 | |
| Secondary | Number of participants with AEs leading to study drug withdrawal | Up to Week 14 | |
| Secondary | Number of deaths | Up to Week 18 | |
| Secondary | Number of participants with AEs of Special Interest (AESIs) | Up to Week 18 | |
| Secondary | Barnes Akathisia Rating Scale (BARS) | Up to Week 14 | |
| Secondary | Abnormal Involuntary Movement Scale (AIMS) | Up to Week 14 | |
| Secondary | Body Weight | Up to Week 14 | |
| Secondary | Body Mass Index (BMI) | Up to Week 14 | |
| Secondary | Number of participants with vital sign abnormalities | Up to Week 18 | |
| Secondary | Number of participants with clinical laboratory abnormalities | Up to Week 14 | |
| Secondary | Number of participants with 12-lead electrocardiogram (ECG) abnormalities | Up to Week 14 | |
| Secondary | Number of participants with suicidal ideation as assessed by the Columbia-Suicide Severity Rating Scale (C-SSRS) | Up to Week 18 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07011732/registered